AMAG PHARMACEUTICALS INC - NOTE 3.250% 6/0

CUSIP: 00163UAD8

Q4 2019 13F Holders as of 31 Dec 2019

Type / Class
Debt / NOTE 3.250% 6/0
Market price (% of par)
84.14%
Total 13F principal
$304,188,440
Principal change
-$1,116,500
Total reported market value
$257,547,955
Number of holders
24
Value change
-$780,102
Number of buys
5
Number of sells
10

Quarterly Holders Quick Answers

What is CUSIP 00163UAD8?
CUSIP 00163UAD8 identifies 00163UAD8 - AMAG PHARMACEUTICALS INC - NOTE 3.250% 6/0 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of AMAG PHARMACEUTICALS INC - NOTE 3.250% 6/0 as of Q4 2019

As of 31 Dec 2019, AMAG PHARMACEUTICALS INC - NOTE 3.250% 6/0 was held by 24 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $304,188,440 in principal (par value) of the bond. The largest 10 bondholders included CITADEL ADVISORS LLC, UBS OCONNOR LLC, Whitebox Advisors LLC, CNH PARTNERS LLC, WOLVERINE ASSET MANAGEMENT LLC, Allianz Asset Management GmbH, TENOR CAPITAL MANAGEMENT Co., L.P., BlackRock Inc., Birch Grove Capital LP, and Context Capital Management, LLC. This page lists 24 institutional bondholders reporting positions for the Q4 2019 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.